Regenyx Medical granted new U.S. Patent further strengthening the IP foundation of the company’s proprietary self-assembling peptide hydrogel platform
This patent further strengthens the IP foundation of Regenyx‘s proprietary self-assembling peptide hydrogel platform, protecting applications across regenerative and aesthetic medicine, including Lipogenyx™ and future applications. The patent provides broad protection for peptide hydrogel compositions and methods for soft tissue repair, reconstruction, regeneration, adipose tissue combinations, and other regenerative medicine applications. This is an important milestone as Regenyx continues advancing their platform and exploring strategic partnerships to accelerate its clinical and commercial potential.
